Thillai Veerapazham Sekar

Therapeutic potential of pterostilbene against pancreatic beta‐cell apoptosis mediated through <scp>N</scp>rf2

Elango Bhakkiyalakshmi, Devibalan Shalini, Thillai Veerapazham Sekar et al. · British Journal of Pharmacology · 2014 · 113 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide <i>in vitro</i> and in a mouse model

Meenakshi Malhotra, Thillai Veerapazham Sekar, Jeyarama S. Ananta et al. · Oncotarget · 2018 · 70 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Reporter Protein Complementation Imaging Assay to Screen and Study Nrf2 Activators in Cells and Living Animals

Kunka Mohanram Ramkumar, Thillai Veerapazham Sekar, Kira Foygel et al. · Analytical Chemistry · 2013 · 45 citations · Full text

Medicine, Molecular Biology, Pharmacology +14

Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001

Shoucheng Ning, Thillai Veerapazham Sekar, Jan Scicinski et al. · Oncotarget · 2015 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +17